First test to predict opioid addiction risk is approved by FDA

Kinga Krzeminska/Moment RF/Getty Images

The Food and Drug Administration (FDA) greenlights the first of its kind test to predict potential risk of opioid addiction. This innovative prescription-only test, AvertD, offers health care professionals a new method to assess if patients might have a higher risk of becoming addicted to opioids before prescribing pain management treatments. The approval of AvertD represents another step forward in the FDA’s efforts to reduce chances of opioid misuse and addiction and support the treatment of those with the disorder.

Source

“FDA Approves First Test to ID Potential Risk of Opioid Addiction.” WebMD, WebMD, 21 Dec. 2023, www.webmd.com/mental-health/addiction/news/20231221/fda-approves-first-test-to-id-potential-risk-of-opioid-addiction.